2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Types of Cancer
- Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian
- Hematologic Malignancies: Leukemia, Lymphoma, Multiple Myeloma
- Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers
- Gender-Specific Cancers: Gynecologic cancers, Prostate cancer
- Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers
Cancer encompasses over 100 distinct types, each originating in different tissues and cells. Commonly known cancers include carcinoma, which arises in epithelial cells, and sarcoma, originating in bone, muscle, or connective tissues. Leukemia targets blood-forming tissues, disrupting normal blood cell production, while lymphoma and myeloma impact the immune system by affecting lymph nodes and plasma cells, respectively.
Recent advancements in cancer research are shedding light on rarer types, like neuroendocrine tumors and pediatric-specific cancers. Scientists are exploring molecular and genetic factors that distinguish each type, fostering breakthroughs in personalized medicine. This research is critical for developing targeted therapies that improve survival rates and quality of life for diverse cancer populations.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation